100999-26-6
100999-26-6
Chemical Structure
CY 208-243
- CAS No.: 100999-26-6
- Formula:C19H18N2
- Molecular Weight:274.36
IUPAC Name: (6aR,12bR)-7-methyl-4,6,6a,7,8,12b-hexahydroindolo[4,3-ab]phenanthridine
InChIKey: WRNKIDLXXXIELU-IEBWSBKVSA-N
SMILES: CN1[C@@](C2)([H])[C@@](C3=CC=CC=C3C1)([H])C4=CC=CC5=C4C2=CN5
Biological Activity: CY 208-243 is a selective dopamine D1 receptor agonist which exhibits antiparkinsonian activity[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CY 208-243 | 99.98% | CY 208-243 is a selective dopamine D1 receptor agonist which exhibits antiparkinsonian activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LE 300 | 98.5% | LE 300 is a potent and selective dopamine D1-like receptor antagonist with Kis of 1.9 nM and 7.5 nM in CHO cell membranes expressing human dopamine D1 and D5 receptors, respectively. LE 300 is an antagonist of the 5-HT2A receptor with a pA2 of 8.32 in a rat tail artery assay. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ecopipam hydrobromide | 99.0% | Ecopipam (SCH 39166) hydrobromide is a potent, selective and orally active antagonist of dopamine D1/D5 receptor, with Kis of 1.2 nM and 2.0 nM, respectively. Ecopipam hydrobromide shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a receptor (Ki=0.98, 5.52, 0.08, and 0.73 μM, respectively). Ecopipam hydrobromide can be used for the research of schizophrenia and obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LY 116467 | LY 116467 is an active compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
RU 27849 | RU 27849 (Compound 27) is a 5-HT receptor 2A agonist, and can be used to study tryptamine recognition site binding. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
VPC13163 | VPC13163 is a potent androgen receptor (AR) BF3 inhibitor with an IC50 of 0.31 µM. VPC13163 has anticancer effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Agroclavine | Agroclavine acts as an agonist of the D1-dopamine receptor and α1-adrenergic receptor. Agroclavine enhances the sensitivity of the brain to magnetic fields; it impairs spatial memory without affecting hippocampal long-term potentiation (LTP). Agroclavine exerts bidirectional regulatory effects on immune activity: it enhances NK cell activity with low toxicity under normal conditions, while it inhibits NK cell activity and exhibits significant cardiac and hepatic toxicity under stress conditions. Agroclavine can be used for research on neuroelectrophysiology, learning and memory, and immunoregulation. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pergolide | 99.68% | Pergolide (LY127809 free base), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptor agonist. Pergolide can be used for Parkinson's disease and hyperprolactinaemia research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ecopipam hydrochloride | 99.46% | Ecopipam (SCH 39166) hydrochloride is a potent, selective and orally active antagonist of dopamine D1/D5 receptor, with Kis of 1.2 nM and 2.0 nM, respectively. Ecopipam hydrochloride shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a receptor (Ki=0.98, 5.52, 0.08, and 0.73 μM, respectively). Ecopipam hydrochloride can be used for the research of schizophrenia and obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ecopipam | 99.77% | Ecopipam (SCH 39166) is a potent, selective and orally active antagonist of dopamine D1/D5 receptor, with Kis of 1.2 nM and 2.0 nM, respectively. Ecopipam shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a receptor (Ki=0.98, 5.52, 0.08, and 0.73 μM, respectively). Ecopipam can be used for the research of schizophrenia and obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dihydrolysergic acid | 99.89% | Dihydrolysergic acid is a fungal ergot alkaloid and also the dihydro analog of lysergic acid. Dihydrolysergic acid serves as a precursor for vasodilatory ergot alkaloid-derived drugs. Dihydrolysergic acid can be biosynthesized by expressing intron-free synthetic Claviceps africana cloA in an Neosartorya fumigata easM knockout strain. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
